April 03, 2019
Rose
Drug makers, insurers and pharmacy benefit managers face mounting pressure from Congress and the public to reduce the high list prices of drugs like insulin.
from Health https://ift.tt/2Ugl3n5
April 03, 2019
Rose
Health, Health - The New York Times
No comments
Related Posts:
A Sudden Coronavirus Surge Brought Out Singapore’s Dark Side- A Visual Dispatch From One of the World’s Most Remote Islands
- All 50 States Have Eased Coronavirus Restrictions
- Hospitals Move Into Next Phase as New York Passes Viral Peak
- Brazil Allows Doctors to Treat Coronavirus Patients With Hydroxychloroquine: Live Coverage
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment